Latest filing published 06 Jun 2016 for CorMedix Inc., €113k.
Insider track record
Matthew Duffy: trading record in brief
Matthew Duffy appears in our data through filings on CorMedix Inc. shares, published by SEC (Form 4). The record holds 10 filings, for trades running from 13 November 2013 to 3 June 2016.
Sales make up the whole of the open-market record (3 sales, €460k). The rest of the record consists of 2 share grants and 4 option exercises. 2016 to date brings no purchases and 1 sale.
The latest filing, published on 6 June 2016, reports an open-market sale of €113k in CorMedix Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Matthew Duffy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 46,106 shares@ US$2.7393.6% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-001038:0
- 21,454 shares@ US$0.406.4% of flowCommon Stock, $0.001 par value per shareSEC:0001638599-16-000929:0
- 15,000 shares@ US$0.28Common Stock, $0.001 par value per shareSEC:0001144204-15-035560:0
- 25,000 shares@ US$0.29Common Stock, $0.001 par value per shareSEC:0001144204-15-035560:1
- 30,000 shares@ US$6.4804Common Stock, $0.001 par value per shareSEC:0001144204-15-035560:2
- 4,884 shares@ US$3.44Common Stock, $0.001 par value per shareSEC:0001144204-15-026789:0
- 28,571 shares@ US$0.35Common Stock, $0.001 par value per shareSEC:0001144204-13-061888:0
7 of 7 declarations
